V

Comprehensive Notes: Blood and the Cardiovascular System (Hematology)

Blood and the Cardiovascular System: Comprehensive Study Notes

  • Overview

    • Cardiovascular system components:
    • A pump: the heart
    • Conducting system: blood vessels
    • Fluid medium: blood
    • Blood is a specialized fluid of connective tissue
    • Blood contains cells suspended in a fluid matrix
    • Blood components include plasma (fluid matrix) and formed elements (cells)
    • Interstitial fluid surrounds cells; blood operates within a closed circulatory system

  • What blood does

    • Transports materials to and from cells:
    • Oxygen (O2) and carbon dioxide (CO2)
    • Nutrients and hormones
    • Immune system components
    • Waste products
    • Blood plays roles in pH and ion regulation, fluid loss control at injury sites, defense against toxins/pathogens, and temperature stabilization

  • Physical characteristics and key facts

    • Important functions of blood (summary):
    • Transportation of dissolved substances
    • Regulation of pH and ions
    • Restriction of fluid losses at injury sites
    • Defense against toxins and pathogens
    • Stabilization of body temperature
    • Blood is a fluid connective tissue with plasma (fluid matrix) and formed elements (cells)
    • Blood volume and consistency vary with sex and body size

  • Blood composition and separation (centrifugation)

    • Whole blood components:
    • Plasma (~55% of whole blood)
    • Erythrocytes (RBCs) (~45% of whole blood)
    • Leukocytes (WBCs) and platelets in buffy coat (<1%)
    • Hematocrit (Hct): percent of blood volume that is RBCs
    • Typical hematocrit values: Hct{ ext{male}} o 47 ext{%} \, ext{±} \,5 ext{%},\ Hct{ ext{female}} o 42 ext{%} \, ext{±} \,5 ext{%}.
    • Note: polycythemia is a high hematocrit; dehydration can elevate hematocrit; anemia results from too few RBCs

  • Plasma: the fluid matrix

    • Plasma is ~90% water
    • Contains >100 dissolved solutes: nutrients, gases, wastes, hormones, proteins, inorganic ions
    • Plasma proteins are the most abundant solutes and remain in blood (not taken up by cells)
    • Major plasma protein groups by fraction of plasma proteins:
    • Albumin ~60%
    • Globulins ~36%
    • Fibrinogen ~4%
    • Albumin functions:
    • Transports substances (fatty acids, thyroid hormones, steroid hormones)
    • Globulins functions:
    • Antibodies (immunoglobulins)
    • Transport globulins (hormone-binding proteins, metalloproteins, apolipoproteins, steroid-binding proteins)
    • Fibrinogen functions:
    • Forms clots; converted to fibrin during coagulation

  • Plasma proteins: origins and roles

    • Over 90% of plasma proteins are produced in the liver
    • Antibodies are produced by plasma cells
    • Peptide hormones are produced by endocrine organs

  • Formed elements: main cell types

    • Erythrocytes (RBCs): complete cells are absent; they are anucleate and lack most organelles
    • Leukocytes (WBCs): complete cells with nuclei and organelles
    • Platelets: cell fragments derived from megakaryocytes
    • Most formed elements survive in the bloodstream only a few days
    • Most blood cells originate in bone marrow and do not divide once matured

  • Erythrocytes (RBCs): structure and function

    • RBCs are biconcave discs that are anucleate and lack organelles; diameter ≈ 7.5 μm and thickness ≈ 2.5 μm (top view vs. side view)
    • Major function: gas transport via hemoglobin (Hb)
    • RBCs contain the plasma membrane protein spectrin, which provides flexibility to change shape
    • RBCs have no mitochondria; ATP production is anaerobic; they do not consume the O2 they transport
    • Hematology insight: RBCs contribute significantly to blood viscosity
    • Composition statistics: RBCs make up the majority of formed elements; RBCs contain >97% hemoglobin by volume (not counting water)
    • Visual notes: in blood smears, RBCs appear as two-dimensional objects due to flatness on slides; in three-dimensional views they show the typical disc shape
    • Life span: about 120 days

  • Hemoglobin (Hb): structure and gas binding

    • Hb structure:
    • Globin: four polypeptide chains (two alpha, two beta)
    • Heme pigment bonded to each globin chain
    • Iron in heme binds O2; each Hb molecule can transport up to four O2 molecules
    • RBCs carry ~250 million Hb molecules each
    • O2 binding states:
    • In lungs: oxyhemoglobin (ruby red)
    • In tissues: deoxyhemoglobin (reduced Hb; dark red)
    • CO2 binding: about 20% of CO2 in the blood binds to Hb as carbaminohemoglobin
    • CO poisoning risk highlighted in clinical contexts

  • RBCs and hemoglobin quantities (reference values)

    • Normal Hb concentrations:
    • Males: ext{Hb}_{ ext{male}} o 13{-}18 rac{ ext{g}}{100 ext{mL}}; \ ext{Females}: 12{-}16 rac{ ext{g}}{100 ext{mL}}
    • Normal RBC counts and other metrics vary by sex and laboratory reference ranges

  • RBC life cycle and destruction

    • RBCs lack protein synthesis, growth, and division; life span ~100–120 days
    • Old RBCs become fragile, Hb degenerate; trapped in narrow capillaries, especially in the spleen
    • Macrophages of the liver, spleen, and bone marrow engulf dying RBCs
    • Phases of degradation:
    • Heme and globin separation
      • Iron salvaged for reuse
      • Heme degraded to bilirubin (yellow pigment); liver secretes bilirubin into bile
      • Bilirubin is processed to urobilinogen and stercobilin (feces)
    • Globin is metabolized to amino acids and released back into circulation

  • Erythropoiesis (RBC formation): overview

    • Location: red bone marrow (reticular connective tissue and blood sinusoids)
    • In adults, primarily in axial skeleton
    • Hematopoietic stem cells (hemocytoblasts) give rise to all formed elements
    • Growth factors and hormones drive differentiation along specific pathways; committed cells cannot revert
    • Erythropoiesis schematic progression (simplified):
    • Stem cell (hemocytoblast) → Proerythroblast → Basophilic erythroblast → Polychromatic erythroblast → Orthochromatic erythroblast → Reticulocyte → Erythrocyte
    • Reticulocytes appear in blood after a short maturation period; mature RBCs lack nuclei

  • Regulation of erythropoiesis (EPO and hormones)

    • Primary stimulus for erythropoiesis is EPO (erythropoietin)
    • Basal EPO levels maintain steady rate; high RBC or low O2 depress production
    • EPO sources: kidneys (major) and some from the liver
    • Physiological triggers:
    • Hypoxia due to hemorrhage, increased RBC destruction, reduced Hb per cell (e.g., iron deficiency), or reduced O2 availability (e.g., high altitude)
    • Effects of EPO:
    • Rapid maturation of committed marrow cells
    • Increased circulating reticulocyte count within 1–2 days
    • External factors affecting RBC production:
    • Athletes may abuse EPO; testosterone can enhance EPO production, increasing RBCs

  • Nutritional and dietary requirements for erythropoiesis

    • Essential nutrients: amino acids, lipids, carbohydrates (support energy and cell synthesis)
    • Iron:
    • Essential component of hemoglobin; ~65% of total body iron in Hb; rest stored in liver, spleen, and bone marrow
    • Free iron ions are toxic; stored as ferritin and hemosiderin; transport in blood bound to transferrin
    • Vitamin B12 and folic acid: required for DNA synthesis in rapidly dividing developing RBCs
    • Iron toxicity is a concern if free iron exceeds transferrin transport capacity; body regulates iron uptake
    • Normal albumin ranges and clinical implications:
    • Albumin normal range: 3.4{-}5.4~ ext{g/dL}
    • Low albumin can indicate malnutrition, liver disease, inflammatory disease; high albumin may reflect acute infections, burns, stress

  • Relevance of plasma proteins and liver function

    • Plasma proteins largely produced in the liver (70–90% of plasma proteins are hepatic in origin depending on the protein class)
    • Antibodies produced by plasma cells (a type of immune cell derived from B lymphocytes)
    • Liver also produces many coagulation factors and transport proteins

  • ABO blood typing and Rh factor

    • ABO system: A, B, AB, O blood groups defined by surface antigens on RBCs
    • Antibodies against the non-self antigens present in plasma
    • ABO compatibility rules:
    • Universal donor: O negative (O−) for red cell transfusion (no A/B antigens or Rh factor in RBCs)
    • Universal recipient: AB positive (AB+) for red cell transfusion (A, B, AB antigens; Rh antigen present)
    • Rh factor:
    • Rh+ or Rh− status determines potential hemolytic reactions in pregnancy and transfusions
    • Rh incompatibility can cause hemolytic disease of the newborn in subsequent pregnancies if an Rh− mother carries an Rh+ fetus

  • White blood cells (leukocytes): overview

    • Leukocytes are nucleated and have organelles; no hemoglobin
    • Primary roles: defend against pathogens, remove toxins and wastes, attack abnormal cells
    • WBC circulation and extravasation (diapedesis):
    • Can migrate out of bloodstream into tissues
    • Exhibit amoeboid movement
    • Exhibit chemotaxis (attracted to chemical stimuli)
    • Some are phagocytic (neutrophils, eosinophils, monocytes)

  • Categories of leukocytes

    • Granulocytes: visible cytoplasmic granules; include neutrophils, eosinophils, basophils
    • Agranulocytes: lack visible granules; include lymphocytes and monocytes
    • Mnemonic for relative abundance: "Never Let Monkeys Eat Bananas" (Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils)

  • Granulocytes detail

    • Neutrophils: most active; first responders to bacterial infection; phagocytose pathogens; degranulation; release defensins, prostaglandins, leukotrienes; can form pus
    • Eosinophils: 2–4% of WBCs; target large parasites; release toxic compounds (nitric oxide, cytotoxic enzymes); modulate allergic responses
    • Basophils: <1% of WBCs; accumulate at damaged sites; release histamine (promotes vasodilation) and heparin (anticoagulant)

  • Agranulocytes detail

    • Lymphocytes: 20–30% of circulating WBCs; migrate in/out of blood; reside in connective tissues and lymphoid organs; essential for specific immune defense
    • Two main types:
    • T lymphocytes (T cells): destroy virus-infected and tumor cells
    • B lymphocytes (B cells): differentiate into plasma cells that produce antibodies
    • Monocytes: 2–8% of circulating WBCs; large and phagocytic; become macrophages in tissues; recruit and activate other immune cells; clear pathogens

  • White blood cell disorders

    • Leukopenia: abnormally low WBC count (drug-induced or disease-related)
    • Leukemias: cancer with overproduction of abnormal WBCs; categorized by the clone involved (myeloid vs lymphocytic)
    • Acute leukemia: stem cell–derived; primarily affects children; chronic leukemia: more common in older adults

  • Platelets and hemostasis (blood clotting)

    • Platelets (thrombocytes): cell fragments involved in clotting; circulate for ~9–12 days; majority reserved in spleen (~2/3)
    • Platelets form a temporary platelet plug to seal small vessel breaks; platelets are short-lived and degenerate after about 10 days
    • Platelet counts: typical range 150{,}000{-}500{,}000 ext{ platelets}/oldsymbol{ ext{μL}}
    • Platelet disorders:
    • Thrombocytopenia: low platelet count
    • Thrombocytosis: high platelet count
    • Platelet functions (three core roles):
    • Release important clotting chemicals
    • Temporarily patch damaged vessel walls
    • Reduce the size of a break in the vessel wall

  • Hemostasis: the stoppage of bleeding

    • Three overlapping phases:
      1) Vascular phase (vascular constriction/spasm): vascular smooth muscle contraction limits blood flow; endothelial cells become sticky and promote platelet adherence
      2) Platelet phase: platelets adhere to exposed surfaces and aggregate to form a platelet plug; platelets release chemicals (ADP, PDGF, Ca2+, platelet factors) that promote further aggregation and vascular repair
      3) Coagulation phase (blood clotting): a cascade of enzymatic reactions forming a fibrin mesh that traps cells and platelets; converts fibrinogen to insoluble fibrin; involves clotting factors (I–XIII); Vitamin K is needed to synthesize several clotting factors
    • Clotting cascade and coagulation more detail:
    • Fibrin forms a mesh; stabilizes the platelet plug into a clot
    • The coagulation phase typically begins ~30 seconds after injury or later, depending on the injury
    • Clot retraction and repair: platelets contract to pull torn vessel edges closer, aiding tissue repair; plasmin-mediated fibrinolysis gradually dissolves the clot as healing occurs
    • Illustrative sequence (simplified):
    • Vascular spasm → Platelet plug formation → Coagulation → Clot formation via fibrin mesh

  • Hemostasis visualization and pathology

    • Visual summaries show the three-phase sequence and the fibrin mesh trapping RBCs/platelets
    • Disorders of hemostasis:
    • Thromboembolic disorders: unwanted clot formation; risk factors include atherosclerosis, slow or stagnant blood flow
    • Bleeding disorders: problems producing or maintaining clots
    • Major thromboembolic terms:
    • Thrombus: clot that forms in an unbroken vessel
    • Embolus: a thrombus that breaks loose and travels in the bloodstream
    • Embolism: obstruction caused by an embolus (e.g., pulmonary or cerebral emboli)

  • Anticoagulant drugs and clinical use

    • Aspirin: antiprostaglandin effect that inhibits thromboxane A2; reduces platelet aggregation; used to lower heart attack risk
    • Heparin: rapid-acting anticoagulant used in clinical settings (pre-/postoperative care)
    • Warfarin (Coumadin): anticoagulant that interferes with vitamin K–dependent clotting factor synthesis; used in patients prone to atrial fibrillation
    • Dabigatran: direct thrombin inhibitor

  • Bleeding disorders and their clinical implications

    • Thrombocytopenia: low platelets; petechiae can appear due to spontaneous hemorrhage; platelets < 50{,}000 ext{/μL} is diagnostic; treatment may include platelet transfusions
    • Hemophilia: hereditary bleeding disorders with deficiencies in clotting factors:
    • Hemophilia A: factor VIII deficiency (~77% of cases)
    • Hemophilia B: factor IX deficiency
    • Hemophilia C: factor XI deficiency (milder type)
    • Symptoms: prolonged bleeding, especially into joints; treatment includes plasma transfusions and factor replacement; higher risk of infections (hepatitis/HIV) with some historical plasma products

  • Anemia: reduced oxygen-carrying capacity

    • Anemia is a symptom/sign rather than a disease itself; manifests as fatigue, pallor, shortness of breath, chills
    • Major causes fall into three groups:
    • Blood loss (acute or chronic hemorrhagic anemia)
    • Low RBC production (iron deficiency, pernicious anemia, aplastic anemia)
    • High RBC destruction (hemolytic anemias, including sickle-cell)
    • Iron-deficiency anemia: caused by hemorrhage, poor iron intake/absorption; treated with iron supplementation
    • Pernicious anemia: autoimmune destruction of stomach mucosa leading to intrinsic factor deficiency and B12 malabsorption; RBCs cannot divide → macrocytes; treatment includes B12 injections or nasal gel; B12 is rich in animal products
    • Aplastic anemia: destruction or inhibition of red marrow by drugs/chemicals/radiation/viruses; all cell lines affected; treatment may involve transfusions and stem cell transplantation
    • High RBC destruction: hemolytic anemias; can be caused by Hb abnormalities, transfusion incompatibilities, infections
    • Sickle-cell anemia:
    • Hb S results from a single amino acid substitution in the beta chain
    • Causes RBCs to sickle under low oxygen or dehydration, leading to occlusion of small vessels and pain
    • Population genetics: common in people of African descent due to malaria resistance; heterozygous trait provides some advantage against malaria

  • Sickle-cell anemia: molecular detail

    • Example Hb sequence change: normal beta chain sequence (e.g., Val–His–Leu–Thr–Pro–Glu–Glu …) vs. sickled sequence (one amino acid substitution in beta chain)

  • White blood cells (in focus)

    • Leukocytes lack hemoglobin and do not typically migrate in the same way as RBCs; they are essential for immune defense
    • They move out of the bloodstream (diapedesis), show amoeboid movement, and chemotax toward inflammation signals

  • Addendum: sepsis (septicemia)

    • Sepsis is a life-threatening emergency when an infection enters the bloodstream
    • High-risk populations: very young, elderly, immunocompromised
    • Symptoms: high fever, faintness, dizziness, altered mental status
    • Rapid treatment with antibiotics is crucial; progression may lead to septic shock and organ failure

  • Addendum: other notes

    • Blood safety and misinformation from popular media: some depictions (e.g., vampires) are not scientifically accurate in terms of blood consumption or memory storage in blood
    • Blood memory in media is not supported by biological evidence; blood does not store memories or memories-like information

  • Quick reference: key numbers and formulas (study prompts)

    • Blood volume in adults: approximately V_{ ext{blood}} o 5{-}6 ext{ L} ext{ (males)}, 4{-}5 ext{ L} ext{ (females)}
    • Hematocrit values:
    • ext{Hct}_{ ext{male}} o 47\% \pm 5\%
    • ext{Hct}_{ ext{female}} o 42\% \pm 5\%
    • RBC lifespan: ext{life span} o 100{-}120 ext{ days}
    • Hb concentration ranges: ext{Hb}{ ext{male}} o 13{-}18 rac{g}{dL}, \ ext{Hb}{ ext{female}} o 12{-}16 rac{g}{dL}
    • RBC production rate: > 2{,}000{,}000 RBCs produced per second
    • Platelet count range: 150{,}000{-}500{,}000 rac{ ext{platelets}}{ ext{μL}}
    • Platelet lifespan: ~9{-}12 ext{ days}
    • Plasma protein fractions: albumin 60\%, globulins 36\%, fibrinogen 4\%
    • Fibrin role: fibrin forms insoluble strands that stabilize a clot

  • Mathematical relationships and essential notes (LaTeX)

    • Hematocrit definition:
    • ext{Hct} = rac{V{ ext{RBC}}}{V{ ext{blood}}} imes 100\%
    • Hemoglobin capacity per Hb molecule:
    • ext{O}2 ext{ capacity per Hb} = 4 imes ext{O}2 ext{ molecules}
    • RBC composition and Hb density: RBCs are >97% Hb by volume (ignoring water)
    • Oxygen loading/unloading reactions (conceptual):
    • ext{Hb} + ext{O}2 ightleftharpoons ext{HbO}2 \ ( ext{oxyhemoglobin})
    • ext{HbO}2 ightarrow ext{Hb} + ext{O}2 \ ( ext{deoxyhemoglobin})

  • Connections and real-world relevance

    • EPO and athletic performance: blood doping risks include increased blood viscosity, higher cardiac workload, and potential fatal cardiovascular events; regulates sports ethics and policy with anti-doping rules
    • Nutritional health: iron, B12, and folate status are critical for preventing anemia; vegetarian/vegan diets may require planning to ensure B12 intake or supplementation
    • Sepsis recognition and rapid treatment are critical for patient outcomes; early antibiotics improve prognosis; supports understanding of immune system interactions with pathogens
    • Understanding ABO and Rh systems informs safe transfusion practices and pregnancy management to prevent hemolytic reactions

  • Ethical, philosophical, and practical implications

    • Ethics of performance-enhancing strategies (e.g., EPO, blood doping) weigh athletic performance against long-term health risks
    • Public health implications of nutrition, infection control, and access to safe blood products
    • Cardiovascular health: balancing blood viscosity and oxygen transport to optimize tissue perfusion without excessive strain on the heart

  • Quick study prompts and takeaways

    • Compare plasma vs. formed elements; identify major plasma proteins and their major roles
    • Memorize RBC structure-function relationships: biconcave shape, spectrin flexibility, lack of mitochondria, high Hb content
    • Recall the stages of erythropoiesis and the hormonal regulation by EPO; understand triggers like hypoxia
    • Differentiate between RBC production vs. destruction; know where macrophages and hemopoietic organs participate in turnover
    • Understand hemostasis: sequence of vascular spasm, platelet plug formation, coagulation cascade, and fibrinolysis
    • Recognize common disorders: anemia (causes), hemophilia types, thrombocytopenia, leukemia, sickle-cell disease
    • Recall anticoagulants and their mechanisms; know practical indications for each (e.g., atrial fibrillation risk management, post-surgical prophylaxis)

  • Endnotes

    • The materials cited are from Pearson Education (2013) and accompanying figures/slides referenced in the transcript
    • Where clinical connections are described (e.g., sepsis, blood doping, or hemostasis disorders), they reflect common medical understanding and educational examples used in physiology curricula